The novel SARS‐CoV‐2 outbreak has raised concerns among patients with rheumatic diseases receiving chronic immunosuppressive therapy. Patient concerns regarding immune response to the virus have fueled non‐adherence behavior.
http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
https://www.riss.kr/link?id=O113120341
2020년
-
0020-7292
1879-3479
SCIE;SCOPUS
학술저널
269-270 [※수록면이 p5 이하이면, Review, Columns, Editor's Note, Abstract 등일 경우가 있습니다.]
0
상세조회0
다운로드다국어 초록 (Multilingual Abstract)
The novel SARS‐CoV‐2 outbreak has raised concerns among patients with rheumatic diseases receiving chronic immunosuppressive therapy. Patient concerns regarding immune response to the virus have fueled non‐adherence behavior.
The novel SARS‐CoV‐2 outbreak has raised concerns among patients with rheumatic diseases receiving chronic immunosuppressive therapy. Patient concerns regarding immune response to the virus have fueled non‐adherence behavior.
Call to action for a South American network to fight COVID‐19 in pregnancy
Reproductive health paradigms in times of COVID‐19